Flu b
Pro Research Analysisby 
Searched over 200M research papers for "flu b"
The Emerging Threat of Influenza B Virus
Introduction to Influenza B Virus
Influenza B virus, often overshadowed by its counterpart, influenza A, has emerged as a significant contributor to the annual flu burden. Historically, influenza B was considered less severe, but recent studies have highlighted its potential to cause severe disease and high mortality rates.
Epidemiology and Lineages of Influenza B
Influenza B was first isolated around 1940 and later divided into two distinct lineages: Yamagata-like and Victoria-like strains. These lineages co-circulate with varying prevalence, contributing to the unpredictability of flu seasons. For instance, in Southern Brazil, both lineages were found to co-circulate, with B/Vic being more prevalent in certain regions and associated with severe acute respiratory infections (SARI).
Clinical Characteristics and Disease Severity
The clinical presentation of influenza B is similar to that of influenza A, with symptoms including fever, cough, and respiratory distress. However, influenza B has been associated with higher hospitalization rates and severe outcomes, especially in children and immunocompromised individuals . During the 2010-2011 flu season, influenza B was responsible for 38% of pediatric deaths, despite only accounting for 26% of circulating strains. Additionally, influenza B infections have been linked to severe complications such as rhabdomyolysis, acute respiratory failure, and post-influenza aspergillosis .
Impact on Specific Populations
Influenza B poses a significant threat to various populations, including children, the elderly, and those with underlying health conditions. In Philadelphia, an outbreak in 1985-1986 saw a high hospitalization rate among children under three years old, with many developing pneumonia and other severe complications. Similarly, a study in Dallas reported severe illness and complications in patients ranging from five to 73 years old, with some cases resulting in death.
Economic and Healthcare Burden
The economic burden of influenza B is substantial, with significant costs associated with hospitalizations, medical treatments, and lost productivity. The unpredictability of circulating strains and vaccine mismatches further exacerbate the impact, leading to increased disease burden during epidemic seasons .
Implications for Vaccination Strategies
Current vaccination strategies often include a trivalent vaccine that covers only one influenza B lineage, which may not provide adequate protection during seasons when the other lineage predominates. This mismatch can lead to higher rates of severe disease and hospitalizations. The development of a universal flu vaccine that targets conserved epitopes on the influenza B virus could potentially mitigate these issues and provide broader protection.
Conclusion
Influenza B virus, once considered the "B team" of influenza viruses, has proven to be a formidable pathogen with significant implications for public health. Its ability to cause severe disease, particularly in vulnerable populations, underscores the need for improved surveillance, vaccination strategies, and public awareness. Continued research and development of universal vaccines are crucial in combating the evolving threat of influenza B.
Sources and full results
Most relevant research papers on this topic